The pharmacological effect of curcumin against NSCLC may be linked with the regulation of CCND1, CASP3, HIF1A, IL-6, MAPK3, STAT3, AKT1, and TP53 targets. The gene discussed is TP53; the disease is non-small cell lung carcinoma.